Sentence examples for a distinct loss from inspiring English sources

In this sort of world we readers find ourselves at a distinct loss.

The lesioned hemisphere (left column) has a distinct loss of ChAT availability when compared with the control hemisphere (right column).

In contrast pattern III and IV reveal marked oligodendropathology. Here, pattern III lesions show signs of a distal oligodendrogliopathy with detection of apoptotic oligodendrocytes, and a distinct loss of MAG or CNPase.

As shown in Fig. 4A, the results revealed that NeuN staining was high in the hippocampal CA1 region in sham (non-ischemic) animals (Fig. 4A, panel a), while ischemia/reperfusion and scrambled-tat injected control groups (Fig. 4A, panels b,c, respectively) showed a distinct loss of NeuN-stained neurons in the CA1 region 7 d after ischemia.

Interestingly, analysis of Vangl2 expression in Crsh mutants showed a distinct loss of Vangl2 enrichment adjacent to the lumen, suggesting that Celsr1 is required to correctly localize Vangl2.

Culture-independent analyses of patients with CD and UC have revealed a distinct loss of symbionts residing within the colonic mucosa as compared to healthy individuals.

The other two families (A and B) are both derived from the kafir race of sorghum, which predominates in temperate latitudes of southern Africa and possesses a distinct loss-of-function allele at the Ma1 locus (Sbprr37-2) (Murphy et al. 2011).

Losses of the CDKN2A ARF CDKN2B locus occurred in 50% of patients, and in one case a distinct biallelic loss was identified.

To exclude the possibility that the lack of effect of the SnoN (KdR) on E-cadherin suppression by TGFβ is due to impairment of potential modifications other than sumoylation, we generated a distinct SUMO loss of function SnoN mutant (SnoN (EdA)) in which Glutamates 52 and 385 within SUMO consensus motifs (ψKXE) in SnoN were converted to alanine residues (Figure 6A).

It has been previously demonstrated that inefficiency of drug use and waste production may lead to a distinct economic loss, though experiences are limited and most studies are dated or focus on other therapeutic areas [ 9- 12].

DOX-resistant cells showed a spectrum of decrease of NCAM surface receptors: distinct loss in IMR-32DOX cells, moderate reduction in UKF-NB-2DOX or UKF-NB-4DOX cells, and slight, non-significant decrease on UKF-NB-3DOX cells.